Floatz logo

AMLODIPINE

Stroke Hemorrhagic

The George InstituteSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Stroke Hemorrhagic cohort.

Asset / SponsorPhaseRating
Lipitor
Duan Chuanzhi
Phase 4BB
Esmolol
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 4BB
Xingnaojing
Peking University Third Hospital
Phase 4BB
MELATONIN
Hospital San Carlos, Madrid
Phase 4BB
Cerebrolysin
Cardinal Stefan Wyszynski University
Phase 4BB

View all 25 →

Same molecule, other indications

AMLODIPINE is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
essential hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →